International Conference on

Rheumatology

Rheumatology-2021

Theme: Multifaceted aspects and enrichments in Rheumatology

Meetings International welcomes you to attend the International Conference on Rheumatology scheduled on Oct 26-27, 2021 in Osaka, Japan. The theme of the conference is “Multifaceted aspects and enrichments in Rheumatology”.

Rheumatology 2021 is dedicated to the diagnosis and the treatment of rheumatic diseases. It is the study of rheumatism, arthritis,and other disorders of the joints, muscles,and ligaments. Rheumatology has turned out to be absolutely a standout amongst the most powerful and imaginative subjects in the majority of the medicines. Therapies for rheumatic diseases continue to expand rapidly. We proudly invites renowned researchers, physicians, surgeons, professors, instrumentalists, medical and industrial professions, young scientists, students and business delegates to share the knowledge and scientific progress in the field of rheumatology for the purpose of shaping the future research.

Session 1: Rheumatology

Rheumatology is a branch of medicine, which is especially meant to adequate diagnosis and therapy of rheumatic diseases. The market size stood at USD 23,822.5 and is projected to reach USD 33,958.4 Million by 2025, exhibiting a CAGR of 4.6% during the forecast period (2018-2025).

Rheumatology Conferences | Rheumatology | Global Rheumatology Conference | Rheumatology Congress | Miscellaneous Rheumatic Diseases Conference | International Surgery Conference on Rheumatology

Session 2: Orthopaedic Surgery

Many orthopaedic surgeons elect to do further training, or fellowships, after completing their residency training. The global orthopaedic surgery equipment market is expected to reach USD 22.8 Billion by 2022 from USD 17.5 Billion in 2017, growing at a CAGR of 5.5% from 2017 to 2022. Rising incidence and prevalence of orthopaedic disorders, and growing geriatric population are some of the major driving factors driving the growth of the global orthopaedic surgery equipment market.

Orthopedic Surgery Conferences | Orthopaedic Surgery Meetings | Orthopedic Surgery Conference | Orthopedic Surgery

Session 3: Rheumatology Nurse Practice

Rheumatology nurse treat patients with rheumatic disease that associated with the muscles, joints and bones. Previous studies in BC have shown that only 39% of the early incident rheumatoid arthritis population and 45% of the prevalent late rheumatoid arthritis population were receiving DMARD therapy, suggesting the existence of large service gaps.

Rheumatology Nurse Practice Conferences | Rheumatology Nurse Practice | Metabolic Bone Disease Meetings | Global Rheumatology Nurse Practice Conference | Rheumatology Nurse Practice Congress | Miscellaneous Rheumatic Diseases Conference | International Surgery Conference on Rheumatology

Session 4: Arthritis

Arthritis is a rheumatic disease that has symptoms of pain, limited movement, swelling and pain in connective tissues. The osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The presence of a large geriatric and target patient population and the improving healthcare infrastructure in several APAC countries are expected to offer growth opportunities in the market during the forecast period.

Arthritis Conferences |  Arthritis Meetings |  Arthritis Conference |  Arthritis Conferences

Session 5: Osteoarthritis

Osteoarthritis is the most widely recognized chronic condition of the joints. As per a study published by the National Centre for Biotechnology Information in 2019, more than 50% of osteoarthritis patients in the US are prescribed NSAIDs. Similarly, in Europe, of the total number of osteoarthritis patients using prescription medications (47%), 60% received NSAIDs.

Osteoarthritis Conferences | Osteoarthritis Meetings | Osteoarthritis Conference | Osteoarthritis Workshop

Session 6: Rheumatoid Arthritis

Rheumatoid arthritis is an autoimmune disease that can cause joint pain and harm all through your body. The joint damage that Rheumatoid arthritis causes often occurs on the two sides of your body. Global revenues from RA drug sales are expected to grow from $26.2B in 2019 to $29.1B in 2029.

Rheumatoid arthritis Conferences | Rheumatoid arthritis Meetings | Rheumatoid arthritis Conference | Rheumatoid arthritis Workshop

Session 7: Bone and Mineral Research

Minerals in bone play the major role in bone health and calcium is the most important mineral to keep the bone healthy. The bony skeleton is a remarkable organ that serves both a structural function and a reservoir function.

Bone and Mineral Research Conferences | Bone and Mineral Research Meetings | Bone and Mineral Research Conference | Bone and Mineral Research | Metabolic Bone Disease 

Session 8: Arthroplasty

Arthroplasty is a surgical replacement or reconstruction technique to restore the activity of the joint. articular surface of a musculoskeletal joint is replaced, remodelled by orthopaedic surgical procedure. Knee Arthroplasty market accounted for US$ 8,804.8 Million in 2019. It is anticipated to grow at a CAGR of 4.5% from 2019 to 2030.

Arthroplasty Conferences | Arthroplasty Meetings | Arthroplasty Conference | Arthroplasty

Session 9: Advances in Pain management

Pain management is the current area of expanding research and clinical exertion in the field of rheumatology. Pain management places executive’s role in why distinctive ways to deal with be managed for chronic pain. The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.

Advances in Pain management Conferences | Advances in Pain management Meetings | Advances in Pain management Conference | Advances in Pain management

The global rheumatoid arthritis drugs/therapeutics market size was valued at USD 20.3 billion in 2016. The market is anticipated to expand at a CAGR of 4.6% over the forecast period. Increasing prevalence of arthritis, growing acceptance of biopharmaceuticals, and presence of well-defined regulatory guidelines in developed economies are among key trends expected to trigger market growth. 

Growing patient awareness regarding rheumatic disorders and influx of latest biopharmaceuticals within the global arena are projected to rev up adoption of atrophic arthritis (RA) therapeutics. In 2013, approximately 52.2 million adults suffered from arthritis in U.S. alone. Most patients who are treated with Disease-Modifying Antirheumatic Drugs (DMARDs) remain unsatisfied thanks to poor therapeutic benefits. For this patient group, a mixture of biologics and DMARDs is probably going to deliver higher therapeutic benefits. Thus, the atrophic arthritis market is witnessing a shift toward combination therapies that provide enhanced results to patients. Rise in penetration of combination of DMARDs and biologics will boost market revenue in coming years.

Meetings International is announcing Young Scientist Awards through International Conference on Rheumatology (Rheumatology 2021) which is scheduled at Osaka, Japan during Oct 26-27, 2021. Rheumatology 2021 and upcoming conferences will recognise participants to summit will work as a discussion point for researchers and experts from all around the world to discuss the cause, effect and medication. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Eligibility: Plenary speakers, Keynote speakers, Invited speakers and Young Researchers as well as for the youth generation. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
Acknowledgement as YRF Awardee
Promotion on the conference website, Young Researcher Awards and certificates
Link on the conference website
Recognition on Meetings Int. Award Page
Chances to coordinate with partners around the world
Research work can be published in the relevant journal without any publication fee

Criteria:
All presented abstracts will automatically be considered for the Award.
All the presentation will be evaluated in the conference venue
All the awards will be selected by the judges of the award category
The winners of the Young Scientist Award will receive award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:
All submissions must be in English.
The topic must fit into scientific sessions of the conference
Each individual participant is allowed to submit maximum 2 papers
Abstract must be submitted online as per the given abstract template
Abstracts must be written in Times New Roman and font size will be 12
Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference

Conditions of Acceptance: To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.

  • Rheumatology
  • Orthopaedic Surgery
  • Rheumatology Nurse Practice
  • Arthritis
  • Osteoarthritis
  • Rheumatoid arthritis
  • Bone and Mineral Research
  • Arthroplasty
  • Advances in Pain management